Board of Directors & Staff
Kenneth W. Rind, PhD
Senior Advisor: Investment Banking at Caris & Company
Dr. Rind is an internationally recognized corporate financier, with over 40 years of experience as: Head of Technology Banking at Oppenheimer (now CIBC); a corporate development executive responsible for developing strategy and managing various acquisitions at Xerox, and a founder of eight venture funds.
Dr. Rind was appointed by the U.S. government and currently serves on the Boards of the U.S. Civilian Research and Development Foundation (CRDF), chartered by Congress to grant cooperative funding to scientists and engineers in the former Soviet Union and beyond; and the U.S Israel Science and Technology Foundation (USISTF), jointly funded by the U.S. and Israeli governments to further technology collaborations. He previously served as an advisor to the U.N. and the U.S.T.R. Countries that have invited Dr. Rind to speak on fostering technology commercialization include: Holland, Belgium, Singapore, Japan, Russia, Ukraine and Israel.
Dr. Rind was a founding Director of the National Venture Capital Association; President of the Connecticut Venture Group and a Director of a Scottish Trust (mutual fund), the first to invest in technology companies world-wide (Baillie Gifford). He has served on the Boards of numerous corporations including 15 that were public and over 25 more that he assisted in finding strategic investors/merger partners. He is currently a Director of the Venture Investors Association of New York (formerly the NYVCF).
In 1981, Dr.Rind co-founded Oxford Partners, an independent venture capital company which managed funds provided by over 25 corporate (strategic) and 20 financially-oriented investors and was the predecessor of Oxford Bioscience. He also co-founded the Nitzanim-AVX/Kyocera Venture Fund in 1993 and the Israel Infinity Venture Capital Fund in 1998, whose successor has formed the first on-shore venture fund in China.
Notable investees from Dr. Rind's venture history include: Intel, Apple, Human Genome Sciences, Genetic Therapy, Geron, Martek, ESC Medical, XTL Biopharmaceuticals, Galileo, Shopping.com and Applied Data Research (the first company to sell software).
Dr.Rind received his PhD from Columbia University in Nuclear Chemistry and his B.A from Cornell. He is an avid tennis player.
